Effective Medical Weight Loss & Weight Health Treatments

Medical weight loss treatments des moines

Get all-inclusive & effective dosing with tirzepatide treatments at Coachlight & Des Moines Plastic Surgery

Coachlight partners with Des Moines Plastic Surgery to offer effective tirzepatide treatments to our guests. We were one of the first practices in Iowa to offer exclusively tirzepatide to guests as it delivers them sustainable results.

What is Tirzepatide? 

Tirzepatide treatments are designed to effectively address long-term weight loss goals and management. Tirzepatide involves a weekly injection that has been proven to reduce appetite.

When combined with a wholesome diet and a healthy, more active lifestyle, tirzepatide has shown great potential in promoting sustainable weight loss. We are pleased to provide tirzepatide treatments at both our Ankeny and West Des Moines locations.

Tirzepatide is a once-weekly injectable peptide medication and is the key element in FDA-approved brands Mounjaro for treating diabetes and Zepbound for combating obesity and excess weight. 

How Does Tirzepatide Work? 

Tirzepatide acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. By activating both the GIP and GLP-1 receptors, it effectively regulates glucose levels , reduces appetize, and promotes weight loss. 

Benefits of a Tirzepatide Treatment

Tirzepatide, acting as a GIP receptor and GLP-1 receptor agonist, yields noteworthy enhancements in glycemic control and substantial weight reduction in individuals with type 2 diabetes.

Additionally, it demonstrates efficacy in the improvement of hemoglobin A1C levels and is utilized off-label for the treatment of obesity. 

Understand this first: What is the difference between tirzepatide & semaglutide?

This is one of our most frequently asked questions. In the prescription medication industry, semaglutide is utilized at higher dosages and marketed as Wegovy for weight loss purposes, while at lower dosages, it is marketed as Ozempic for the treatment of diabetes. Similarly, tirzepatide is marketed as Mounjaro for FDA-approved diabetes treatment, while Zepbound is the brand name for its marketing as an obesity and weight management solution. 

BOTH ARE PEPTIDES: Both tirzepatide and semaglutide are medications that are currently known for and utilized for treating type 2 diabetes and obesity. Belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class of drugs, they share certain similarities but also exhibit notable differences. 

MECHANISM OF ACTION: Tirzepatide functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. By activating both the GIP and GLP-1 receptors, it effectively regulates glucose levels, reduces appetite and promotes weight loss. In contrast, semaglutide is a selective GLP-1 (singular) receptor agonist that primarily targets and activates the GLP-1 receptor. This mechanism improves glycemic control and has the potential for weight loss. 

EFFECTIVNESS – ONE PERFORMS BETTER: Clinical trials have shown that both tirzepatide and semaglutide have significant potential for weight loss. However, tirzepatide has exhibited a more pronounced effect on weight reduction compared to semaglutide. Studies suggest that tirzepatide may have a greater impact on reducing weight in individuals with obesity or overweight, surpassing the effects of semaglutide. As a practice we value the best interest of our guests and only offer tirzepatide as a medical weight loss option as we want guests who make this investment to get the best performing product available.

Non-Surgical Weight Loss Treatments ad

Determine If You’re a Tirzepatide Candidate by Scheduling a FREE Phone Consult at Des Moines Plastic Surgery

Before, During, and After

What To Expect Before A Tirzepatide Treatment 

Guests interested in tirzepatide injectable treatments in the greater Des Moines area should complete an initial complimentary phone consultation to determine suitability as a candidate for the treatment.

During the consultation, we will review your medical history and discuss the treatment, expectations, and potential side effects in detail. If deemed a suitable candidate, an appointment for the first dose can be scheduled. 

What To Expect During A Tirzepatide Treatment 

During the initial appointment and administration, you will undergo weight measurement, body measurements, lifestyle practices review, and a discussion of expectations while receiving tirzepatide treatments. The first dose will be administered and a provider will go over and teach you how to administer additional once-a-week doses. Our tirzepatide program consists of a series of eight once-a-week treatments.

The convenience lies in the fact that after the first dose, the subsequent seven doses can be taken home and self-administered weekly. Upon completing the final (eighth) dose, patients will return for a follow-up appointment at our facility to evaluate weight loss outcomes and determine the subsequent course of action, including the continuation of additional treatments. We will also assess and make appropriate dosage adjustments as necessary. 

What To Expect After A Tirzepatide Treatment 

Upon completing the initial 8-week treatment phase, we will evaluate your progress and long-term weight loss goals. If you aim to maintain your current weight, we will recommend continuing treatments at a maintenance dosage. The ultimate goal will be to gradually reduce the dose until you no longer require or desire weekly treatments. Alternatively, if you wish to achieve further weight loss, we will create a continued weekly dosage plan and make appropriate recommendations. 

It’s important to note that clinical studies with tirzepatide and semaglutide have shown weight loss in subjects who received the medication for an average period of 3 to 6 months. Establishing lasting, healthy lifestyle habits and behaviors through dietary adjustments and physical activity is crucial for sustainable long-term weight loss and weight health. Your commitment to these changes will contribute to maintaining the weight loss achieved while using tirzepatide treatments. 


More Frequently Asked Questions

Tirzepatide is a promising diabetes drug that has recently shown the potential to impact appetite and aid in weight loss. This novel medication works by targeting receptors in the brain that regulate food intake, resulting in increased feelings of satiety after meals.

In clinical trials, patients treated with tirzepatide reported significant reductions in hunger and cravings, leading to improved dietary choices and decreased overall caloric intake. Moreover, the drug has been shown to have a positive effect on blood sugar levels and cardiovascular health, making it a promising option for those struggling with both diabetes and obesity.  

The active ingredient tirzepatide is sold under the brand name Mounjaro for its FDA approval to treat diabetes, and under the brand name Zepbound for its FDA approval to treat obesity and excess weight. 

Tirzepatide is a once-weekly administered medication provided in a pre-filled pen. To prevent gastrointestinal side effects, such as nausea and vomiting, which are more likely at higher doses, the dosage should be gradually titrated. It is crucial to begin with a low dose and gradually increase it over several weeks. 

The duration of tirzepatide treatment may vary based on starting weight, weight loss goals, and overall health. The most suitable treatment plan will be customized for each individual, potentially involving different dosages and treatment lengths. 

In clinical trials, tirzepatide has demonstrated impressive weight loss results for participants within 16 weeks. This exciting news brings hope to individuals who have struggled to lose weight for months or even years. Although the outcomes may vary based on factors like diet and exercise habits, tirzepatide has the potential to revolutionize weight loss efforts, providing a fast and efficient method for shedding pounds. 

To maintain long-term weight loss results while utilizing tirzepatide treatments, it is critical to establish healthy lifestyle habits and behaviors through diet and physical activity. Your accountability to these changes will contribute to sustaining the weight loss. 

Tirzepatide provides synergistic anti-obesity effects by reducing appetite and energy intake while improving metabolic function. It increases energy expenditure through the activation of receptors that boost metabolic rate, resulting in increased calorie burn and gradual weight loss. 

Possible side effects of this medication may include swelling, redness, and itching at the injection site. It may also cause tiredness, loss of appetite, nausea, vomiting, upset stomach, diarrhea, or constipation. It is important to note that serious side effects are rare among most individuals who use this medication. 

The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) injection for the chronic weight management of adults with obesity (body mass index of 30 kg/m2 or greater) or overweight (body mass index of 27 kg/m2 or greater) who have at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol). It is to be used alongside a reduced-calorie diet and increased physical activity. 

While tirzepatide has shown promising results in clinical trials, experts emphasize the importance of lifestyle changes, such as diet and exercise, alongside the use of tirzepatide. Ultimately, the decision of whether to use tirzepatide as a standalone treatment or in combination with other interventions will depend on individual needs and circumstances.

There are no specific dietary restrictions while taking tirzepatide. However, it is advisable to follow a balanced diet that includes nutrient-dense foods. Unlike appetite suppressants that work by reducing the desire to eat, tirzepatide regulates blood sugar levels to help control hunger. 

Tirzepatide is an FDA-approved novel medication for the treatment of type 2 diabetes mellitus. Due to its potent weight loss properties, tirzepatide can be used off-label for obesity. 

Tirzepatide has recently shown potential in enhancing metabolic parameters for weight loss. Clinical trials reveal significant reductions in body weight and improved blood sugar regulation for Type 2 diabetes patients. Specifically, tirzepatide reduces HbA1c levels, serving as a marker for long-term blood sugar control. Additionally, it improves lipid profiles and blood pressure, further contributing to metabolic health. 

The ultimate objective of tirzepatide treatments in West Des Moines and Ankeny for weight loss is to help you reach your desired healthy goal weight initially. Subsequently, with maintenance monitoring and management, the dosage will gradually decrease to eventually ‘wean’ you off the treatment. Your commitment to a healthy diet and active lifestyle will directly impact your ability to sustain long-term weight loss. 

Tirzepatide is FDA-approved for use in adults over the age of 18. However, for now, the drug has not been tested on younger individuals, which means there is no data to suggest that it is safe or effective for use in children or adolescents.  

Regarding “Ozempic face,” it’s a term colloquially used to describe the weight loss side effect associated with semaglutide, the active ingredient in Ozempic. Obviously this is a more “broad” application as the same “side effect” could occur with tirzepatide. Weight loss can sometimes lead to a noticeable reduction in facial fat, resulting in a more defined or gaunt appearance.

As for whether someone on tirzepatide could experience similar changes in facial appearance due to weight loss, it’s theoretically possible. Weight loss, especially significant and rapid weight loss, can affect the distribution of fat in the body, including the face. However, it’s essential to note that individual responses to medications can vary widely, and not everyone will experience the same side effects or changes in appearance.

If you’re concerned about potential changes in your facial appearance while taking tirzepatide, it’s best to discuss your concerns with your provider. Our medical aesthetic professionals can recommend collagen treatments like Sculptra Aesthetic or dermal filler treatments as relevant.

CoolSculpting is a non-invasive procedure that uses controlled cooling to target and eliminate fat cells, primarily for body contouring purposes. EMSCULPT, on the other hand, is a non-invasive treatment that uses high-intensity focused electromagnetic energy to induce muscle contractions, primarily for muscle toning and strengthening.

If you’re considering undergoing treatments like CoolSculpting or EMSCULPT while being on tirzepatide, you can schedule a complimentary consultation first to determine if you’re a good candidate for these types of treatments. There’s no specific contraindication that prohibits undergoing these procedures concurrently with tirzepatide, and many guests that have been on our tirzepatide treatments have benefited from doing CoolSculpting and EMSCULPT treatments as recommended by their provider on what they’re an ideal candidate for.

What People Are Saying

Coachlight is known as a destination of beauty and wellness and Iowa’s top medical aesthetic provider, serving guests with Des Moines Plastic Surgery for over 15 years.


Our Locations


Questions?
Send Us A Message!

Name(Required)
This field is for validation purposes and should be left unchanged.